Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

SENTINEL Investigators

Research output: Contribution to journalArticlepeer-review

1043 Scopus citations

Fingerprint

Dive into the research topics of 'Natalizumab plus interferon beta-1a for relapsing multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences